Logo image of MELE.BR

MELEXIS NV (MELE.BR) Stock Fundamental Analysis

EBR:MELE - Euronext Brussels - BE0165385973 - Common Stock - Currency: EUR

73.25  +0.05 (+0.07%)

Fundamental Rating

6

MELE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 51 industry peers in the Semiconductors & Semiconductor Equipment industry. MELE scores excellent points on both the profitability and health parts. This is a solid base for a good stock. MELE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

MELE had positive earnings in the past year.
In the past year MELE had a positive cash flow from operations.
In the past 5 years MELE has always been profitable.
Each year in the past 5 years MELE had a positive operating cash flow.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

With an excellent Return On Assets value of 19.17%, MELE belongs to the best of the industry, outperforming 90.20% of the companies in the same industry.
With an excellent Return On Equity value of 30.21%, MELE belongs to the best of the industry, outperforming 80.39% of the companies in the same industry.
MELE has a better Return On Invested Capital (23.13%) than 88.24% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MELE is significantly above the industry average of 15.12%.
The last Return On Invested Capital (23.13%) for MELE is well below the 3 year average (31.03%), which needs to be investigated, but indicates that MELE had better years and this may not be a problem.
Industry RankSector Rank
ROA 19.17%
ROE 30.21%
ROIC 23.13%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

MELE's Profit Margin of 18.38% is in line compared to the rest of the industry. MELE outperforms 58.82% of its industry peers.
MELE's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 23.57%, MELE is doing good in the industry, outperforming 64.71% of the companies in the same industry.
In the last couple of years the Operating Margin of MELE has grown nicely.
Looking at the Gross Margin, with a value of 43.03%, MELE is in line with its industry, outperforming 41.18% of the companies in the same industry.
MELE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.57%
PM (TTM) 18.38%
GM 43.03%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MELE is creating value.
The number of shares outstanding for MELE remains at a similar level compared to 1 year ago.
Compared to 5 years ago, MELE has more shares outstanding
The debt/assets ratio for MELE is higher compared to a year ago.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 8.68 indicates that MELE is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.68, MELE is in the better half of the industry, outperforming 68.63% of the companies in the same industry.
The Debt to FCF ratio of MELE is 1.78, which is an excellent value as it means it would take MELE, only 1.78 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.78, MELE is in the better half of the industry, outperforming 60.78% of the companies in the same industry.
MELE has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
MELE's Debt to Equity ratio of 0.38 is on the low side compared to the rest of the industry. MELE is outperformed by 70.59% of its industry peers.
Although MELE does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 1.78
Altman-Z 8.68
ROIC/WACC2.09
WACC11.09%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

MELE has a Current Ratio of 4.54. This indicates that MELE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.54, MELE belongs to the top of the industry, outperforming 86.27% of the companies in the same industry.
A Quick Ratio of 2.01 indicates that MELE has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.01, MELE is doing good in the industry, outperforming 74.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 2.01
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

MELE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.50%.
MELE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.04% yearly.
The Revenue has decreased by -9.03% in the past year.
MELE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.89% yearly.
EPS 1Y (TTM)-32.5%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-53.44%
Revenue 1Y (TTM)-9.03%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-18.02%

3.2 Future

MELE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.99% yearly.
MELE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.75% yearly.
EPS Next Y-25.62%
EPS Next 2Y-0.54%
EPS Next 3Y4.79%
EPS Next 5Y9.99%
Revenue Next Year-11.57%
Revenue Next 2Y0.06%
Revenue Next 3Y3.24%
Revenue Next 5Y4.75%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

MELE is valuated rather expensively with a Price/Earnings ratio of 20.75.
MELE's Price/Earnings ratio is a bit cheaper when compared to the industry. MELE is cheaper than 66.67% of the companies in the same industry.
MELE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.29.
Based on the Price/Forward Earnings ratio of 17.51, the valuation of MELE can be described as rather expensive.
66.67% of the companies in the same industry are more expensive than MELE, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.74, MELE is valued at the same level.
Industry RankSector Rank
PE 20.75
Fwd PE 17.51
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MELE indicates a somewhat cheap valuation: MELE is cheaper than 60.78% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MELE indicates a rather cheap valuation: MELE is cheaper than 82.35% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 23.66
EV/EBITDA 11.76
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

MELE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.9
EPS Next 2Y-0.54%
EPS Next 3Y4.79%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.50%, MELE has a reasonable but not impressive dividend return.
MELE's Dividend Yield is rather good when compared to the industry average which is at 1.12. MELE pays more dividend than 100.00% of the companies in the same industry.
MELE's Dividend Yield is a higher than the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 3.5%

5.2 History

The dividend of MELE is nicely growing with an annual growth rate of 10.98%!
Dividend Growth(5Y)10.98%
Div Incr Years3
Div Non Decr Years6
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

87.19% of the earnings are spent on dividend by MELE. This is not a sustainable payout ratio.
The dividend of MELE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP87.19%
EPS Next 2Y-0.54%
EPS Next 3Y4.79%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

MELEXIS NV

EBR:MELE (7/8/2025, 10:17:22 AM)

73.25

+0.05 (+0.07%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-30 2025-07-30
Inst Owners15.6%
Inst Owner ChangeN/A
Ins Owners25.01%
Ins Owner ChangeN/A
Market Cap2.96B
Analysts78.89
Price Target65.42 (-10.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.5%
Yearly Dividend3.7
Dividend Growth(5Y)10.98%
DP87.19%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.09%
Min EPS beat(2)-38.45%
Max EPS beat(2)-1.73%
EPS beat(4)1
Avg EPS beat(4)-9.23%
Min EPS beat(4)-38.45%
Max EPS beat(4)9.1%
EPS beat(8)4
Avg EPS beat(8)-4.63%
EPS beat(12)7
Avg EPS beat(12)-0.24%
EPS beat(16)10
Avg EPS beat(16)2.37%
Revenue beat(2)0
Avg Revenue beat(2)-4.03%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-2.83%
Revenue beat(4)0
Avg Revenue beat(4)-2.93%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.68%
Revenue beat(8)1
Avg Revenue beat(8)-2.02%
Revenue beat(12)4
Avg Revenue beat(12)-1.17%
Revenue beat(16)6
Avg Revenue beat(16)5.08%
PT rev (1m)4.44%
PT rev (3m)-1.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.35%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.25%
Valuation
Industry RankSector Rank
PE 20.75
Fwd PE 17.51
P/S 3.17
P/FCF 23.66
P/OCF 16.61
P/B 5.21
P/tB 5.23
EV/EBITDA 11.76
EPS(TTM)3.53
EY4.82%
EPS(NY)4.18
Fwd EY5.71%
FCF(TTM)3.1
FCFY4.23%
OCF(TTM)4.41
OCFY6.02%
SpS23.09
BVpS14.05
TBVpS14.02
PEG (NY)N/A
PEG (5Y)0.9
Profitability
Industry RankSector Rank
ROA 19.17%
ROE 30.21%
ROCE 27.83%
ROIC 23.13%
ROICexc 24.13%
ROICexgc 24.17%
OM 23.57%
PM (TTM) 18.38%
GM 43.03%
FCFM 13.41%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
ROICexc(3y)38.83%
ROICexc(5y)36.08%
ROICexgc(3y)39.06%
ROICexgc(5y)36.42%
ROCE(3y)37.33%
ROCE(5y)34.27%
ROICexcg growth 3Y-14.81%
ROICexcg growth 5Y1.87%
ROICexc growth 3Y-14.47%
ROICexc growth 5Y2.21%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
F-Score5
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 1.78
Debt/EBITDA 0.8
Cap/Depr 111.24%
Cap/Sales 5.69%
Interest Coverage 20.46
Cash Conversion 66.58%
Profit Quality 72.96%
Current Ratio 4.54
Quick Ratio 2.01
Altman-Z 8.68
F-Score5
WACC11.09%
ROIC/WACC2.09
Cap/Depr(3y)136.47%
Cap/Depr(5y)110.04%
Cap/Sales(3y)6.76%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.5%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-53.44%
EPS Next Y-25.62%
EPS Next 2Y-0.54%
EPS Next 3Y4.79%
EPS Next 5Y9.99%
Revenue 1Y (TTM)-9.03%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-18.02%
Revenue Next Year-11.57%
Revenue Next 2Y0.06%
Revenue Next 3Y3.24%
Revenue Next 5Y4.75%
EBIT growth 1Y-15.83%
EBIT growth 3Y13.74%
EBIT growth 5Y24.11%
EBIT Next Year-15.16%
EBIT Next 3Y8.75%
EBIT Next 5Y10.24%
FCF growth 1Y236.29%
FCF growth 3Y6.64%
FCF growth 5Y13.04%
OCF growth 1Y5817.76%
OCF growth 3Y7.8%
OCF growth 5Y13.55%